Sahota will be replaced by Pfizer executive Susan Rienow on an interim basis until the board picks a successor. (Gerd Altmann/Pixabay) After Novo Nordisk breached not one, not two, but seven clauses ...

Angelini was ruled in breach of Clause 2 of the 2021 Code in relation to an in-person presentation by a contracted speaker at a company-organised promotional meeting, and its recording, which ...

The move to make pharma more transparent and build a positive reputation is the key theme to come out of the launch of the new ABPI Code of Practice during Code Awareness Week. The move to make pharma ...

Novo Nordisk’s two-year suspension from the Association of the British Pharmaceutical Industry (ABPI) for serious breaches of the ABPI Code of Practice has come to an end [1]. Novo Nordisk’s return to ...

Martindale Pharma, Pierre Fabre, Janssen and Pharmasure have all been named in advertisements for breaching the Association of the British Pharmaceutical Industry’s Code of Practice. Martindale Pharma ...

A U.K. pharma trade group suspended Novo Nordisk’s membership for two years after marketing efforts for its obesity drug were deemed a breach of the group’s standards. ABPI said it took the action ...

Novo Nordisk has reached the end of its two-year suspension from the Association of the British Pharmaceutical Industry (ABPI) for breaches of its code of practice, after showing "significant and ...

Pharmaceutical companies promoting prescription-only medicines to health professionals and other relevant decision makers in the UK must now adhere to revised industry standards that came into ...

More detailed requirements for pharmaceutical companies’ relationships with patient groups and health professionals will be included in the revised ABPI Code of Practice which comes into effect on ...